Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study (Q37162738)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 June 2013

Language	Label	Description	Also known as
English	Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study	scientific article published on 19 June 2013

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study (English)

1 reference

Europe PubMed Central

18 August 2017

diabetic nephropathy

1 reference

based on heuristic

inferred from title

author name string

Daniel W Coyne

1

1 reference

Europe PubMed Central

18 August 2017

Dennis L Andress

2

1 reference

Europe PubMed Central

18 August 2017

Michael J Amdahl

3

1 reference

Europe PubMed Central

18 August 2017

Eberhard Ritz

4

1 reference

Europe PubMed Central

18 August 2017

Dick de Zeeuw

5

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

19 June 2013

1 reference

Europe PubMed Central

18 August 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

18 August 2017

28

1 reference

Europe PubMed Central

18 August 2017

2260-2268

1 reference

Europe PubMed Central

18 August 2017

9

1 reference

Europe PubMed Central

18 August 2017

copyright license

Creative Commons Attribution-NonCommercial 3.0 Unported

6 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Use of vitamin D in chronic kidney disease patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Treatment of hyperphosphatemia with sevelamer hydrochloride in dialysis patients: effects on vascular calcification, bone and a close look into the survival data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Association of oral calcitriol with improved survival in nondialyzed CKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Hyperphosphatemia of chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

6 September 2017

Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Serum phosphate levels and mortality risk among people with chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Comparison of the effects of calcitriol and maxacalcitol on secondary hyperparathyroidism in patients on chronic haemodialysis: a randomized prospective multicentre trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Immulite 2000 parathyroid hormone assay: stability of parathyroid hormone in EDTA blood kept at room temperature for 48 h.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3769981

3 September 2018

Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT227

21 January 2018

Vitamin D levels and patient outcome in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT227

21 January 2018

No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation, CRP, calcium overload and a high calcium-phosphate product: a "liaison dangereuse"

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low dose calcitriol versus placebo in patients with predialysis chronic renal failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D levels and early mortality among incident hemodialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis: vitamin D compounds in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone markers predict cardiovascular events in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dismal long-term survival of dialysis patients after acute myocardial infarction: can we alter the outcome?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23787544

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/NDT/GFT227

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37162738&oldid=1864587471"